MAYO STEPHEN 1849061 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-05-31 | 2023-05-26 | 4 | Mayo Stephen | DIRECTOR | holding | 100.0 | 0 | 0.0 | 0.0 | Direct | Common Stock | MERCK & CO., INC. | NA | 2537.44 (MRK) | ||
2023-08-09 | 2023-08-07 | 2023-08-07 | 4 | Mayo Stephen | DIRECTOR | dsp | 10000.0 | 28.31 | 0.6 | 4.29 | Direct | Common Stock | ALLOGENE THERAPEUTICS, INC. | code S | 25328.0 | 167.63 (ALLO) |
2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Mayo Stephen | DIRECTOR | acq | 1846.0 | 18.92 | 0.2 | 0.0 | Direct | Common Stock | SAREPTA THERAPEUTICS, INC. | code A | 9756.0 | 93.55 (SRPT) |
2024-03-06 | 2024-03-05 | 2024-03-05 | 4 | Mayo Stephen | DIRECTOR | dsp | 3135.0 | 32.13 | 0.34 | 122.96 | Direct | Common Stock | SAREPTA THERAPEUTICS, INC. | code S | 6621.0 | 93.55 (SRPT) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-05-31 | 2023-05-26 | 2023-05-26 | 4 | Mayo Stephen | DIRECTOR | acq | 1980.7329 | 26.66 | 0.01 | 111.07 | Direct | Phantom Stock | MERCK & CO., INC. | code A | 7430.3599 | 2537.44 (MRK) |
2023-06-15 | 2023-06-13 | 2023-06-13 | 4 | Mayo Stephen | DIRECTOR | acq | 116120.0 | 100.0 | 7.96 | 5.7 | Direct | Stock Option (Right To Buy) | ALLOGENE THERAPEUTICS, INC. | code A | 116120.0 | 145.84 (ALLO) |
2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Mayo Stephen | DIRECTOR | acq | 3679.0 | 100.0 | 0.39 | 128.67 | Direct | Stock Option (Right To Buy) | SAREPTA THERAPEUTICS, INC. | code A | 3679.0 | 93.55 (SRPT) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)